US trade action threatens Brazilian AIDS programmeBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7283.383 (Published 17 February 2001) Cite this as: BMJ 2001;322:383
- Gavin Yamey
International health agencies have condemned the US government for threatening the Brazilian policy of providing free drugs to patients infected with HIV.
The US government has initiated legal proceedings against Brazil, through the World Trade Organisation's dispute settlement body, claiming that Brazil's production of generic HIV drugs breaks international laws on patent protection.
Brazilian laws provide patent protection to foreign drug companies if they manufacture their product in Brazil. These laws have allowed local Brazilian companies to manufacture generic HIV drugs at low cost. The United States has complained to the World Trade Organisation that this requirement for local production discriminates against the US …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial